Age: 61 Independent Director since: 2017 Committee(s): Audit, Chair Quality, Product Supply, and Technology Other Public Boards: Nevro Corp. (2014-2025) Surmodics, Inc. (2015 2020) Entellus Medical, Inc. (2014-2018) Education: B.S., Accounting, Arizona State University M.B.A., University of Minnesota s Carlson School of Management Certified Public Accountant (inactive) Qualifications: Financial / Capital Markets expertise developed through his experience in finance leadership roles, including service as CFO for several public companies, helps Mr. McCormick bring valuable knowledge of financial oversight and reporting to our Board. Industry and Technology experience gained through more than three decades working in the healthcare and medical device industries adds valuable industry perspective to our Board. Additionally, his significant career in the medical sector and with medical device companies have given him a deep understanding of technologies in our industry that are core to the Company s business and strategy. Manufacturing / Operations / Supply Chain experience gained as COO of Lutonix, enable Mr. McCormick to offer invaluable insights and perspectives regarding the Company s manufacturing, operations and supply chain strategies and related initiatives. Experience: Chief Financial Officer, Aldevron, LLC , a technology company specializing in the manufacture of plasmid DNA, mRNA and proteins (2020 2022, several months after Aldevron was acquired by Danaher Corporation) Held executive management roles at various public and private medical device companies (2009 2015), including as Chief Financial Officer, Tornier N.V. , a global orthopedic company (2012 2015 when Tornier merged with Wright Medical Group, Inc.) Held various management positions at Medtronic plc , including in corporate development and finance (1992 - 2009)